Eikon Therapeutics
Victoria Ho is an accomplished professional in the field of clinical research and development, currently serving as Executive Director of Clinical R&D Process, Documentation, and Learning Management at Eikon Therapeutics since April 2023. With extensive experience spanning over two decades, Victoria held various leadership positions at Gilead Sciences from September 2000 to May 2019, including Senior Director and Clinical Program Manager. Previous roles include Clinical Research Associate at Chiron Corporation and Covance, and Regional Clinical Research Monitor at Olsten Kimberly Quality Care/Eli Lilly. Victoria began a career in clinical research as a Clinical Study Coordinator at California Clinical Trials. Victoria earned a Bachelor of Arts in Molecular and Cell Biology from the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
Eikon Therapeutics
3 followers
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases.